FDPS, a key enzyme in the mevalonate (MEV) pathway, plays an important role in vascular stiffness and angiogenesis (Han et al. 2016; Chichger et al. 2019), which suggests that it may affect pulmonary hypertension. This evidence concerns the gene FDPS and pulmonary hypertension.